Search For "interstitial lung disease"
What is Pulmonary Fibrosis?
Updated : 10 months, 2 weeks ago IST
New Delhi [India], April 30: Pulmonary fibrosis (PF) is a progressive interstitial lung disease (ILD) characterized by excessive fibrotic tissue deposition in the pulmonary parenchyma. The term "pulmonary" refers to the lungs, while "fibrosis" denotes pathological scarring. The disease disru
Read More
Daughter Appeals for Support via Crowdfunding to Fund Lung Transplant Surg
Updated : 2 years, 3 months ago IST
Chennai (Tamil Nadu) [India], December 2: In a heartfelt plea, Bavatharani is urgently seeking financial assistance for her mother, Rajeshwari, who is suffering from Interstitial lung disease (ILD) and is in urgent need of a lung transplant at Kauvery Hospital, Alwarpet, Chennai.
Read More
More insight into risk factors for new-onset interstitial lung disease in
Updated : 2 years, 4 months ago IST
New research on the prevalence and risk factors for new-onset interstitial lung disease (ILD) among individuals with systemic sclerosis who previously tested negative for ILD.
Read More
Study discovers risk factors for new-onset interstitial lung disease in sy
Updated : 5 months, 1 week ago IST
The prevalence and risk factors for new-onset interstitial lung disease (ILD) among previously ILD-negative systemic sclerosis patients are reported in new research presented at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting.
Read More
Hospitalization during COVID-19 damages lungs: Study
Updated : 3 years, 3 months ago IST
COVID-19 often leads to a number of health issues as side-effects even after one recovers from it. According to a study by American Thoracic Society, a number of COVID-19 patients suffer from lung disease after being discharged from hospitals.
Read More
Study suggests new biomarker speeds identification of lung disease
Updated : 3 years, 7 months ago IST
Washington [US], July 26 (ANI): During a recent study, a new diagnostic method could help identify one of the deadliest types of interstitial lung disease (ILD) sooner, allowing for faster treatment and improved patient outcomes.
Read More
Glenmark introduces NINDANIB (Nintedanib) and is amongst the first to laun
Updated : 5 years, 5 months ago IST
Mumbai (Maharashtra) [India], October 14 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today launched NINDANIB (Nintedanib 100 and 150 mg capsules) for the treatment of pulmonary fibrosis in India.
Read More